Format

Send to

Choose Destination
Pancreas. 2015 Jul;44(5):686-92. doi: 10.1097/MPA.0000000000000369.

Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.

Author information

1
From the *Kenner Family Research Fund, New York, NY; †Department of Medicine, Mayo Clinic, Rochester, MN; ‡Sawgrass Leadership Institute, Ponte Vedra Beach, FL; and §Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.

Abstract

Innovation leading to significant advances in research and subsequent translation to clinical practice is urgently necessary in early detection of sporadic pancreatic cancer. Addressing this need, the Early Detection of Sporadic Pancreatic Cancer Summit Conference was conducted by Kenner Family Research Fund in conjunction with the 2014 American Pancreatic Association and Japan Pancreas Society Meeting. International interdisciplinary scientific representatives engaged in strategic facilitated conversations based on distinct areas of inquiry: Case for Early Detection: Definitions, Detection, Survival, and Challenges; Biomarkers for Early Detection; Imaging; and Collaborative Studies. Ideas generated from the summit have led to the development of a Strategic Map for Innovation built upon 3 components: formation of an international collaborative effort, design of an actionable strategic plan, and implementation of operational standards, research priorities, and first-phase initiatives. Through invested and committed efforts of leading researchers and institutions, philanthropic partners, government agencies, and supportive business entities, this endeavor will change the future of the field and consequently the survival rate of those diagnosed with pancreatic cancer.

PMID:
25938853
PMCID:
PMC4467583
DOI:
10.1097/MPA.0000000000000369
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center